“卖青苗”是业内人士对新药转让的一种形象比喻。自CMO试点项目“花落”张江后,生物医药企业再也不用含泪“卖青苗”。CMO对普通人来说,可能一辈子都不一定了解。但对于张江生物医药企业来说,是一项跨时代的创新。多年前,采访张江企业,很多人都用同一个词形容生物医药产业阳春白雪。其中,有一点让海外归国创业者想不通的是,在国内医药企业必须自己搭建厂房,才能走完新药的生产阶段,真正量产上市。“卖青苗”就是业内人士对新药转让的一种形象比喻,是指国内医药企业和药品研发机构在技术 “Sell young seedlings ” is the image of the industry transfer of new drugs analogy. Since the CMO pilot project “flowers fall ” after Zhang Jiang, bio-pharmaceutical companies no longer have tears “selling green seedlings ”. CMO for ordinary people, may not understand all one’s life. But for Zhangjiang bio-pharmaceutical companies, it is a cross-age innovation. Years ago, an interview with Zhangjiang Enterprises, many people use the same word to describe the bio-pharmaceutical industry spring snow. Among them, one thing overseas returnees who can not figure out is that in the domestic pharmaceutical companies must build their own plants, in order to finish the new drug production stage, the actual mass market. “Sell young seedlings ” is the image of the industry insiders on the transfer of new drugs, refers to the domestic pharmaceutical companies and drug research and development institutions in technology